Clinical trial
PCSK9 Inhibitor: a New Tool to Fight Septic Shock
NCT03634293 is registered in ClinicalTrials.gov with Wolfson Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PCSK9 Inhibitor: a New Tool to Fight Septic Shock
- Lead sponsor
- Wolfson Medical Center
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- January 31, 2019
- Completion date
- February 28, 2021
- Enrollment
- 712 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sepsis, septic shock